CD19 (Emfizatamab biosimilar) Antibody from ABBEXA LTD
Search, find, compare suppliers for anti-CD19 (Emfizatamab biosimilar) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD19 (Emfizatamab biosimilar) |
| Clone | monoclonal |
| Host Species | Recombinant |
| Reactive Species | human |
| Isotype | n/a |
| Format | Protein A purified |
| Size | 100 µg, 1 mg, |
| Concentration | 1 mg/ml |
| Applications | n/a |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | This product is for research use only (RUO) by laboratories. It is not suitable for use in humans or as a medicine. Emfizatamab is a monoclonal antibody targeting CD19, expressed in Mammalian cells. |
| Immunogen | n/a |
| Other Names | Emfizatamab, CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain, Tumor necrosis factor receptor superfamily member 9, CD137, 4-1BB ligand receptor, CDw137, TNFRSF9, T-cell antigen ILA, T-cell antigen 4-1BB homolog, ILA |
| Gene, Accession # | UniProt: P15391, Q9NZQ7, P07766, Q07011 |
| Catalog # | abx832137 |
| Price | please inquire |
| Order / More Info | CD19 (Emfizatamab biosimilar) Antibody from ABBEXA LTD |
| Product Specific References | n/a |
ABBEXA LTD
ABBEXA LTD
181 Cambridge Science Park
Cambridge, CB4 0GJ UK
P: +44 (0) 1223 755950
Customer Service: info@abbexa.com
Technical Support: support@abbexa.com
Orders: orders@abbexa.com
https://www.abbexa.com
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950
Profile of ABBEXA LTD
Return to Antibodies